Expierience Gingerbread Village by taking advantage of our Holiday Family package and receive 20% off your 2nd night when booking two or more nights! To reserve our Holiday Family Package, use booking code HOL.
A local holiday tradition since 1993, the Sheraton Grand Seattle presents the 28th annual Gingerbread Village: Buzzing Back. View these larger than life gingerbread houses created by our talented culinary team in partnership with children from JDRF's Northwest Chapter and architects from 4D, CRTKL, Master Builders and MG2. Gingerbread Village is free to attend and will be open to the public from November 22, 2022 - January 1, 2023. Viewing hours for Gingerbread Village are Sunday through Thursday from 9:00am to 9:00pm and Friday and Saturday from 9:00am to 11:00pm. All donations collected at the event will directly benefit the Juvenile Diabetes Research Foundation’s Northwest Chapter. Throughout the duration of the Gingerbread Village event, the hotel will also host Jingle Bar, a holiday pop-up bar featuring a holiday-themed menu, festive cocktails, and live music performances every Friday and Saturday night in December.
Gingerbread Village returns for the first time since 2019.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Their mission is to improve lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications. JDRF works every day to change the reality of this disease for millions of people—and to prevent anyone else from ever knowing it—by funding research; advocating for government support of research and new therapies; ensuring new therapies come to market and are recommended by healthcare providers; and connecting, engaging, and educating the T1D community. Founded by parents determined to find a cure for their children with T1D, JDRF expanded through grassroots fundraising and advocacy efforts to become a powerhouse in the scientific community with dozens of U.S. locations and five international affiliates. They have funded about $2.5 billion in research to date and have made significant progress in understanding and fighting the disease.